199 related articles for article (PubMed ID: 24251326)
21. Colorectal cancer in patients with esophageal adenocarcinoma.
Vaughan TL; Kiemeney LA; McKnight B
Cancer Epidemiol Biomarkers Prev; 1995 Mar; 4(2):93-7. PubMed ID: 7742728
[TBL] [Abstract][Full Text] [Related]
22. Dating the rise of esophageal adenocarcinoma: analysis of Connecticut Tumor Registry data, 1940-2007.
Abrams JA; Sharaiha RZ; Gonsalves L; Lightdale CJ; Neugut AI
Cancer Epidemiol Biomarkers Prev; 2011 Jan; 20(1):183-6. PubMed ID: 21127287
[TBL] [Abstract][Full Text] [Related]
23. Trends in esophageal cancer incidence by histology, United States, 1998-2003.
Trivers KF; Sabatino SA; Stewart SL
Int J Cancer; 2008 Sep; 123(6):1422-8. PubMed ID: 18546259
[TBL] [Abstract][Full Text] [Related]
24. Risk of second primary cancer among esophageal cancer patients: a pooled analysis of 13 cancer registries.
Chuang SC; Hashibe M; Scelo G; Brewster DH; Pukkala E; Friis S; Tracey E; Weiderpass E; Hemminki K; Tamaro S; Chia KS; Pompe-Kirn V; Kliewer EV; Tonita JM; Martos C; Jonasson JG; Dresler CM; Boffetta P; Brennan P
Cancer Epidemiol Biomarkers Prev; 2008 Jun; 17(6):1543-9. PubMed ID: 18559572
[TBL] [Abstract][Full Text] [Related]
25. Impact of prior malignancy on outcomes of stage IV esophageal carcinoma: SEER based study.
Saad AM; Al-Husseini MJ; Elgebaly A; Aboshady OA; Salahia S; Abdel-Rahman O
Expert Rev Gastroenterol Hepatol; 2018 Apr; 12(4):417-423. PubMed ID: 29316808
[TBL] [Abstract][Full Text] [Related]
26. Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome: evidence from population-based and clinical cohorts.
Huang KP; Weinstock MA; Clarke CA; McMillan A; Hoppe RT; Kim YH
Arch Dermatol; 2007 Jan; 143(1):45-50. PubMed ID: 17224541
[TBL] [Abstract][Full Text] [Related]
27. Predicting the Future Burden of Esophageal Cancer by Histological Subtype: International Trends in Incidence up to 2030.
Arnold M; Laversanne M; Brown LM; Devesa SS; Bray F
Am J Gastroenterol; 2017 Aug; 112(8):1247-1255. PubMed ID: 28585555
[TBL] [Abstract][Full Text] [Related]
28. Risk of Second Lung Cancer in Patients with Previously Treated Lung Cancer: Analysis of Surveillance, Epidemiology, and End Results (SEER) Data.
Thakur MK; Ruterbusch JJ; Schwartz AG; Gadgeel SM; Beebe-Dimmer JL; Wozniak AJ
J Thorac Oncol; 2018 Jan; 13(1):46-53. PubMed ID: 28989038
[TBL] [Abstract][Full Text] [Related]
29. Alcohol consumption and the risks of adenocarcinoma and squamous cell carcinoma of the esophagus.
Pandeya N; Williams G; Green AC; Webb PM; Whiteman DC;
Gastroenterology; 2009 Apr; 136(4):1215-24, e1-2. PubMed ID: 19250648
[TBL] [Abstract][Full Text] [Related]
30. Second primary cancers in patients with lung carcinoma.
Levi F; Randimbison L; Te VC; La Vecchia C
Cancer; 1999 Jul; 86(1):186-90. PubMed ID: 10391579
[TBL] [Abstract][Full Text] [Related]
31. Incidence of invasive cancers following squamous cell skin cancer.
Levi F; Randimbison L; La Vecchia C; Erler G; Te VC
Am J Epidemiol; 1997 Nov; 146(9):734-9. PubMed ID: 9366621
[TBL] [Abstract][Full Text] [Related]
32. Second primary cancers in men with prostate cancer: an increased risk of male breast cancer.
Thellenberg C; Malmer B; Tavelin B; Grönberg H
J Urol; 2003 Apr; 169(4):1345-8. PubMed ID: 12629357
[TBL] [Abstract][Full Text] [Related]
33. Risk of a new primary cancer among patients with lung cancer of different histological types.
Teppo L; Salminen E; Pukkala E
Eur J Cancer; 2001 Mar; 37(5):613-9. PubMed ID: 11290437
[TBL] [Abstract][Full Text] [Related]
34. Fruit and vegetable intake and esophageal cancer in a large prospective cohort study.
Freedman ND; Park Y; Subar AF; Hollenbeck AR; Leitzmann MF; Schatzkin A; Abnet CC
Int J Cancer; 2007 Dec; 121(12):2753-60. PubMed ID: 17691111
[TBL] [Abstract][Full Text] [Related]
35. The incidence and risk of developing a second primary esophageal cancer in patients with oral and pharyngeal carcinoma: a population-based study in Taiwan over a 25 year period.
Lee KD; Lu CH; Chen PT; Chan CH; Lin JT; Huang CE; Chen CC; Chen MC
BMC Cancer; 2009 Oct; 9():373. PubMed ID: 19843324
[TBL] [Abstract][Full Text] [Related]
36. Androgens and esophageal cancer: What do we know?
Sukocheva OA; Li B; Due SL; Hussey DJ; Watson DI
World J Gastroenterol; 2015 May; 21(20):6146-56. PubMed ID: 26034350
[TBL] [Abstract][Full Text] [Related]
37. Tamoxifen exposure and risk of oesophageal and gastric adenocarcinoma: a population-based cohort study of breast cancer patients in Sweden.
Chandanos E; Lindblad M; Jia C; Rubio CA; Ye W; Lagergren J
Br J Cancer; 2006 Jul; 95(1):118-22. PubMed ID: 16755290
[TBL] [Abstract][Full Text] [Related]
38. Incidence and survival differences in esophageal cancer among ethnic groups in the United States.
Chen Z; Ren Y; Du XL; Yang J; Shen Y; Li S; Wu Y; Lv M; Dong D; Li E; Li W; Liu P; Yang J; Yi M
Oncotarget; 2017 Jul; 8(29):47037-47051. PubMed ID: 28410201
[TBL] [Abstract][Full Text] [Related]
39. Anthropometry and esophageal cancer risk in the European prospective investigation into cancer and nutrition.
Steffen A; Schulze MB; Pischon T; Dietrich T; Molina E; Chirlaque MD; Barricarte A; Amiano P; Quirós JR; Tumino R; Mattiello A; Palli D; Vineis P; Agnoli C; Misirli G; Boffetta P; Kaaks R; Rohrmann S; Bueno-de-Mesquita HB; Peeters PH; May AM; Spencer EA; Allen NE; Bingham S; Tjønneland A; Halkjaer J; Overvad K; Stegger J; Manjer J; Lindkvist B; Hallmanns G; Stenling R; Lund E; Riboli E; Gonzalez CA; Boeing H
Cancer Epidemiol Biomarkers Prev; 2009 Jul; 18(7):2079-89. PubMed ID: 19567501
[TBL] [Abstract][Full Text] [Related]
40. Trends in Esophageal Cancer Mortality and Stage at Diagnosis by Race and Ethnicity in the United States.
Corona E; Yang L; Esrailian E; Ghassemi KA; Conklin JL; May FP
Cancer Causes Control; 2021 Aug; 32(8):883-894. PubMed ID: 34003396
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
